Medical Devices News

BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more details about future product features across its global portfolio at the upcoming 19th annual Advanced Technologies and Treatments for Diabetes Conference in Barcelona, March 11-14, 2026. “There is no better global stage than ATTD to showcase how we’re...

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced its upcoming participation in multiple investor conferences in March 2026, including hosted fireside chats and one-on-one meetings with institutional investors. Cantor Global Technology & Industrial Growth Conference When: Wednesday, March 11, 2026 Location: New York Hilton Midtown, 1335 Avenue of the Americas, New York, NY 10019 Format: Fireside chat (in-person participation only) and one-on-one meetings...

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the FIVE S 6.5 sterile single-use bronchoscope. The device offers a valuable new option for critical care physicians, intensivists, RTs, and ICU-based proceduralists seeking airway control solutions for high-risk patients—especially those managing heavy secretions or in urgent situations requiring fast airway clearance. “The FIVE S 6.5 single-...

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc., a clinical-stage pharmaceutical company developing a novel oral therapy targeting thioredoxin-interacting protein (TXNIP) for diabetes and metabolic disorders, is pleased to highlight new research by investigators at the University of Alabama at Birmingham (UAB) Comprehensive Diabetes Center. The study demonstrates that its oral compound, TIX100, effectively prevents weight rebound following discontinuation of GLP-1 treatment in a mouse model of...

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the following upcoming investor conferences. Oppenheimer’s 36th Annual Healthcare, MedTech & Services Virtual Conference: Tuesday, March 17, 2025 at 10:40am ET. Webcast link here. Sidoti Small Cap Virtual Conference: Wednesday, March 18, 2026 at 1:00pm ET. Webcast link here. The webcast can be accessed at the above links or on Varex’s website at http://www.var...

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck Inc., a digital platform for cognitive assessment and care, today announced that Stephen Bekanich, M.D., has joined the company as Chief Medical Officer. In this role, Dr. Bekanich will lead BrainCheck’s clinical strategy and help expand its value-based and collaborative care initiatives as the company continues to scale nationally. Dr. Bekanich brings decades of experience in geriatric medicine, palliative care, accountable care organizatio...

BOSTON--(BUSINESS WIRE)--Etiometry, a leader in AI-driven clinical intelligence, released findings from a recent economic impact analysis highlighting the significant benefits of AI tools like the Etiometry Platform in improving outcomes and resource allocation in hospitals for critically ill patients. By leveraging advanced analytics and AI-powered insights, the platform empowers care teams to detect subtle changes in patient conditions, prevent complications, and improve recovery times, all l...

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc., the leader in research ultrasound, today announced the release of a significant update for its Vantage NXT Research Ultrasound platform. The release introduces advanced hardware integration capabilities, expanded support for focused ultrasound (FUS) applications, enhanced real-time data synchronization tools, and compatibility with the new M8dV Matrix Array Transducer. The update is available immediately to all Vantage NXT customers. Key Featu...

CANTON, Mass.--(BUSINESS WIRE)--MEDITECH is expanding its Expanse AI portfolio to further improve the clinician experience, empower patients, and maximize financial performance....

GAITHERSBURG, Md.--(BUSINESS WIRE)--Announcing GeneDx's new genetic testing program with Zevra Therapeutics to support patients with suspected Niemann–Pick disease type C (NPC)....